Health & clinical servicesAwardedThe buyer says it suits small firms

RMH clonoSEQ® Assay

A tender from The Royal Marsden NHS Foundation Trust.

Public bodyThe Royal Marsden NHS Foundation Trust
WhereKensington and Chelsea, London
Value£1.2m
Published22 Dec 2025
How it was boughtDirect award: given to a chosen firm without a competition.
Contract19 Jan 2031
Won byNot named in the notice
Awarded for£1.2m
Awarded on22 Dec 2025
BidsNot published

Official notice on Find a Tender ↗

Similar open tenders nearby

This tender has closed. Open tenders like it, in Kensington and Chelsea and elsewhere in London:

Get alerts for tenders like this. Start free and get 7 days of Professional, with job alerts, no card. After that, searching every tender stays free with one weekly job alert; daily alerts are from £19 a month.

Get alerts for tenders like thisSearch all tenders like this

What the notice says

The procurement of a next-generation sequencing (NGS)–based test assay designed for the detection and monitoring of minimal residual disease (MRD) in patients with certain haematologic malignancies, such as multiple myeloma, acute lymphoblastic leukaemia (ALL), and chronic lymphocytic leukaemia (CLL). The required goods and services include: • Provision of assay kits and reagents suitable for the intended patient population. • Use of a software platform for analysis and reporting of results. • Training and technical support for laboratory and clinical staff to ensure accurate sample processing, data interpretation, and integration into clinical workflows. • Ongoing technical support, maintenance, and updates for both hardware (if applicable) and software components. • Delivery of consumables and reagents on a schedule that aligns with clinical demand, ensuring continuity of patient testing. • Compliance with all relevant regulatory standards (e.g., CE-IVD, UKCA marking) and data protection requirements for patient information. • Optional: Integration with existing laboratory information management systems (LIMS) and electronic health records (EHR), if required. • MRD sensitivity threshold of 10-5 or lower • Must work on DNA • Performance data must be supported by evidence generated in relevant disease specific Clinical Trials • Recognised technology included in clinical guidelines • Ability to track clonal evolution

Past health & clinical services jobs at The Royal Marsden NHS Foundation Trust

The latest of the 19 contracts in this trade it awarded in the last five years, with who won them.

ContractWon byValueBidsAwarded
The provision of West London Targeted Lung Health Check ProgrammeInhealth Limited£28m121 Sep 2026
EuroClonality-NDC panelUniv8 Genomics Ltd.£171k–15 Jun 2026
MMprofilerSkylineDx BV£636k–19 Mar 2026
Validation of Pharmacy Aseptic UnitT-SQUARED Validair£64k–2 Mar 2026
RMH - ACE PCR reagent rentalELITech UK Ltd£474k–20 Feb 2026
RMH - Radiopharmaceuticals XielXiel Ltd£2.4m–11 Feb 2026
RMH Radiopharmaceuticals GENot named£120k–11 Feb 2026
Contract for Netspot (Gallium Ga 68 Dotatate)Not named£317k–8 Dec 2025

Typically 1 bids. That is the middle figure for the 5 health & clinical services contracts The Royal Marsden NHS Foundation Trust awarded in the last five years that published a bid count (from 1 to 1).

The Royal Marsden NHS Foundation Trust's health & clinical services contracts ending soon

With who holds them now, over the next 18 months.

ContractHeld byValueEnds
Validation of Pharmacy Aseptic UnitT-SQUARED Validair£64k1 Dec 2026
EuroClonality-NDC panelUniv8 Genomics Ltd.£171k28 Jun 2027
Supply of Truseq compatible Duplex Y adaptorsIntegrated DNA Technologies£674k20 Oct 2027
MMprofilerSkylineDx BV£636k31 Oct 2027
RMH Radiopharmaceuticals GENot named£120k1 Mar 2028
RMH - Radiopharmaceuticals XielXiel Ltd£2.4m11 Mar 2028

More: All of The Royal Marsden NHS Foundation Trust’s tenders · Tenders in Kensington and Chelsea · Tenders in London

Tenders and awards from Find a Tender, Contracts Finder, Public Contracts Scotland and Sell2Wales; contracts ending also from councils' own contract registers. Contains public sector information licensed under the Open Government Licence v3.0.